Now Offering
COVID-19 monoclonal antibodies
Middletown Medical is proud to offer monoclonal antibody treatment for COVID-19 patients. Early treatment has been proven to prevent hospitalization and reduce the risk of death.
Time-Sensitive Treatment
Act Within 72 Hours of Diagnosis
Recommended treatment is within 72 hours of COVID-19 diagnosis, and patients should inquire about treatment as soon as they receive a positive result. However, treatment can be given up to 10 days post-diagnosis.
Monoclonal antibodies are currently the only recognized treatment for COVID-19 to help prevent hospitalization.
Standard Charge
$2,250
Middletown Medical’s standard charge for this cutting-edge therapy. Contact us to verify your eligibility.
(845) 342-4774Verify Your Eligibility
Request a Telemedicine Appointment
Contact us to learn more and to verify your eligibility for monoclonal antibody treatment.
Frequently Asked Questions
About Monoclonal Antibody Treatment
What are monoclonal antibodies?
Monoclonal antibodies are laboratory-produced molecules that act as substitute antibodies, which can restore, enhance, or mimic the immune system's attack on cells.
How do monoclonal antibodies treat COVID-19?
Monoclonal antibodies for COVID-19 may block the virus from attaching to human cells, making it more difficult for the virus to reproduce and cause harm. They may also neutralize the virus.
How do I receive the treatment?
Monoclonal antibody treatments for COVID-19 are only administered in settings where healthcare providers have immediate access to medications to treat a severe infusion reaction, such as anaphylaxis, and the ability to activate emergency medical services (EMS). Middletown Medical's Infusion Center features the latest infusion technology and a specialized team to monitor your care during treatment.